Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$1.15 - $1.89 $32,451 - $53,333
28,219 Added 136.21%
48,936 $68,000
Q4 2022

Feb 14, 2023

BUY
$0.96 - $1.6 $19,888 - $33,147
20,717 New
20,717 $23,000
Q2 2022

Aug 15, 2022

BUY
$0.67 - $1.4 $15,840 - $33,098
23,642 New
23,642 $31,000
Q2 2018

Aug 14, 2018

SELL
$9.36 - $13.25 $211,994 - $300,099
-22,649 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$8.49 - $11.82 $19,527 - $27,186
-2,300 Reduced 9.22%
22,649 $231,000
Q4 2017

Feb 14, 2018

BUY
$8.97 - $23.38 $223,792 - $583,307
24,949
24,949 $245,000

Others Institutions Holding SELB

About SELECTA BIOSCIENCES INC


  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.